IBDEI1T4 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,30250,0)
 ;;=A69.20^^135^1374^50
 ;;^UTILITY(U,$J,358.3,30250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30250,1,3,0)
 ;;=3^Lyme Disease,Unspec
 ;;^UTILITY(U,$J,358.3,30250,1,4,0)
 ;;=4^A69.20
 ;;^UTILITY(U,$J,358.3,30250,2)
 ;;=^5000375
 ;;^UTILITY(U,$J,358.3,30251,0)
 ;;=A69.22^^135^1374^52
 ;;^UTILITY(U,$J,358.3,30251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30251,1,3,0)
 ;;=3^Neurologic Disorders d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,30251,1,4,0)
 ;;=4^A69.22
 ;;^UTILITY(U,$J,358.3,30251,2)
 ;;=^5000377
 ;;^UTILITY(U,$J,358.3,30252,0)
 ;;=A69.21^^135^1374^51
 ;;^UTILITY(U,$J,358.3,30252,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30252,1,3,0)
 ;;=3^Meningitis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,30252,1,4,0)
 ;;=4^A69.21
 ;;^UTILITY(U,$J,358.3,30252,2)
 ;;=^5000376
 ;;^UTILITY(U,$J,358.3,30253,0)
 ;;=A69.29^^135^1374^18
 ;;^UTILITY(U,$J,358.3,30253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30253,1,3,0)
 ;;=3^Conditions d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,30253,1,4,0)
 ;;=4^A69.29
 ;;^UTILITY(U,$J,358.3,30253,2)
 ;;=^5000379
 ;;^UTILITY(U,$J,358.3,30254,0)
 ;;=A69.23^^135^1374^5
 ;;^UTILITY(U,$J,358.3,30254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30254,1,3,0)
 ;;=3^Arthritis d/t Lyme Disease
 ;;^UTILITY(U,$J,358.3,30254,1,4,0)
 ;;=4^A69.23
 ;;^UTILITY(U,$J,358.3,30254,2)
 ;;=^5000378
 ;;^UTILITY(U,$J,358.3,30255,0)
 ;;=A51.0^^135^1374^29
 ;;^UTILITY(U,$J,358.3,30255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30255,1,3,0)
 ;;=3^Genital Syphilis,Primary
 ;;^UTILITY(U,$J,358.3,30255,1,4,0)
 ;;=4^A51.0
 ;;^UTILITY(U,$J,358.3,30255,2)
 ;;=^5000272
 ;;^UTILITY(U,$J,358.3,30256,0)
 ;;=A52.3^^135^1374^54
 ;;^UTILITY(U,$J,358.3,30256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30256,1,3,0)
 ;;=3^Neurosyphilis,Unspec
 ;;^UTILITY(U,$J,358.3,30256,1,4,0)
 ;;=4^A52.3
 ;;^UTILITY(U,$J,358.3,30256,2)
 ;;=^5000298
 ;;^UTILITY(U,$J,358.3,30257,0)
 ;;=A52.10^^135^1374^53
 ;;^UTILITY(U,$J,358.3,30257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30257,1,3,0)
 ;;=3^Neurosyphilis Symptomatic,Unspec
 ;;^UTILITY(U,$J,358.3,30257,1,4,0)
 ;;=4^A52.10
 ;;^UTILITY(U,$J,358.3,30257,2)
 ;;=^5000291
 ;;^UTILITY(U,$J,358.3,30258,0)
 ;;=A52.9^^135^1374^49
 ;;^UTILITY(U,$J,358.3,30258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30258,1,3,0)
 ;;=3^Late Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,30258,1,4,0)
 ;;=4^A52.9
 ;;^UTILITY(U,$J,358.3,30258,2)
 ;;=^5000308
 ;;^UTILITY(U,$J,358.3,30259,0)
 ;;=A53.9^^135^1374^79
 ;;^UTILITY(U,$J,358.3,30259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30259,1,3,0)
 ;;=3^Syphilis,Unspec
 ;;^UTILITY(U,$J,358.3,30259,1,4,0)
 ;;=4^A53.9
 ;;^UTILITY(U,$J,358.3,30259,2)
 ;;=^5000310
 ;;^UTILITY(U,$J,358.3,30260,0)
 ;;=B37.3^^135^1374^17
 ;;^UTILITY(U,$J,358.3,30260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30260,1,3,0)
 ;;=3^Candidiasis Vulva/Vagina
 ;;^UTILITY(U,$J,358.3,30260,1,4,0)
 ;;=4^B37.3
 ;;^UTILITY(U,$J,358.3,30260,2)
 ;;=^5000615
 ;;^UTILITY(U,$J,358.3,30261,0)
 ;;=B58.9^^135^1374^82
 ;;^UTILITY(U,$J,358.3,30261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30261,1,3,0)
 ;;=3^Toxoplasmosis,Unspec
 ;;^UTILITY(U,$J,358.3,30261,1,4,0)
 ;;=4^B58.9
 ;;^UTILITY(U,$J,358.3,30261,2)
 ;;=^5000733
 ;;^UTILITY(U,$J,358.3,30262,0)
 ;;=A59.01^^135^1374^83
 ;;^UTILITY(U,$J,358.3,30262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,30262,1,3,0)
 ;;=3^Trichomonal Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,30262,1,4,0)
 ;;=4^A59.01
 ;;^UTILITY(U,$J,358.3,30262,2)
 ;;=^121763
 ;;^UTILITY(U,$J,358.3,30263,0)
 ;;=B59.^^135^1374^66
 ;;^UTILITY(U,$J,358.3,30263,1,0)
 ;;=^358.31IA^4^2
